1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Oligonucleotide Synthesis Market by Product & Services, Application, End-User - Global Forecast to 2020

The oligonucleotide synthesis market is poised to reach USD 1,918.6 million by 2020 from USD 1,078.1 million in 2015, growing at a CAGR of 10.1% from 2015 to 2020. This market is categorized on the basis of products and services, applications, end users, and regions.

Major factors contributing to the growth of the global oligonucleotide synthesis market include increasing R&D expenses in the pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes.

The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology also play a vital role in the development of this market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market.

North America commands the largest share of the global oligonucleotide synthesis market in 2015 and is expected to witness the second-highest growth rate from 2015 to 2020. According to the Centers for Disease Control and Prevention (CDC), in 2014, chronic diseases accounted for 7 out of 10 deaths and 86% of healthcare costs in the U.S. It was reported that ~50% of Americans suffer from at least one chronic disease. Considering the potential of oligonucleotides (therapeutic oligonucleotides) in the treatment of chronic diseases, the oligonucleotide synthesis market is expected to flourish in the coming years, provided these drugs get rapid market approvals.

Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years.

In addition, the company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments; and levels of output in order to remain successful.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the oligonucleotide synthesis market. The report analyzes the oligonucleotide synthesis market by products and services, application, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the oligonucleotide synthesis market
- Competitive Assessment: In-depth assessment of market strategies, market shares, regional and business segments, and product portfolios of the leading players in the oligonucleotide synthesis market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for oligonucleotide synthesis across regions
- Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the oligonucleotide synthesis market

Table Of Contents

Oligonucleotide Synthesis Market by Product and Services, Application, End-User - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 MARKET SIZE ESTIMATION 26
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.3 KEY INDUSTRY INSIGHTS 32
2.4 ASSUMPTIONS FOR THE STUDY 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 38
4.1 OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW 38
4.2 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS and SERVICES 38
4.3 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION 39
4.4 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER 40
4.5 GEOGRAPHIC SNAPSHOT OF THE OLIGONUCLEOTIDE SYNTHESIS MARKET 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 43
5.2 MARKET SEGMENTATION 43
5.2.1 BY PRODUCTS and SERVICES 43
5.2.2 BY APPLICATION 44
5.2.3 BY END USER 44
5.2.4 BY REGION 44
5.3 MARKET DYNAMICS 45
5.3.1 DRIVERS 46
5.3.1.1 Increasing RandD expenditure in pharmaceutical and biotechnology companies 46
5.3.1.2 Growing field of molecular diagnostics 46
5.3.1.3 Increasing government investments to develop genomic technologies 47
5.3.1.4 Rise in venture capital investments 47
5.3.1.5 Increasing demand for synthetic genes 47
5.3.2 RESTRAINTS 48
5.3.2.1 Price erosion of synthesized oligos 48
5.3.2.2 Lack of regulations for therapeutic oligos 48
5.3.3 OPPORTUNITIES 49
5.3.3.1 Emerging Asian markets 49
5.3.3.2 Developing field of next-generation sequencing 50
5.3.4 CHALLENGES 51
5.3.4.1 Localization of business 51
5.3.4.2 Large-scale synthesis of oligonucleotides 51
6 INDUSTRY INSIGHTS 52
6.1 INTRODUCTION 52
6.1.1 INDUSTRY TRENDS 52
6.2 PORTER'S FIVE FORCES ANALYSIS 53
6.2.1 THREAT FROM NEW ENTRANTS 53
6.2.2 THREAT FROM SUBSTITUTES 54
6.2.3 BARGAINING POWER OF SUPPLIERS 54
6.2.4 BARGAINING POWER OF BUYERS 54
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 54
6.3 SUPPLY CHAIN ANALYSIS 55
6.3.1 KEY INFLUENCERS 56
7 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS and SERVICES 57
7.1 INTRODUCTION 58
7.2 SYNTHESIZED OLIGONUCLEOTIDES 59
7.2.1 SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT 61
7.2.1.1 Primers 62
7.2.1.2 Probes 64
7.2.1.3 Large-scale synthesis oligos 65
7.2.1.4 Intermediate-scale synthesis oligonucleotides 67
7.2.2 SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE 69
7.2.2.1 Custom Oligonucleotides 70
7.2.2.2 Pre-designed oligonucleotides 71
7.2.3 REAGENTS 73
7.2.4 EQUIPMENT 75

8 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION 78
8.1 INTRODUCTION 79
8.2 RESEARCH 80
8.2.1 PCR 83
8.2.2 QPCR 84
8.2.3 SEQUENCING 86
8.2.4 GENE SYNTHESIS 88
8.2.5 OTHER RESEARCH APPLICATIONS 90
8.3 DIAGNOSTICS 92
8.4 THERAPEUTICS 95
8.4.1 DNA/ANTISENSE OLIGOS 98
8.4.2 RNAI 99
8.4.3 NUCLEIC ACID APTAMERS 101
8.4.4 OTHER THERAPEUTIC APPLICATIONS 103
9 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER 105
9.1 INTRODUCTION 106
9.2 ACADEMIC RESEARCH INSTITUTES 107
9.3 DIAGNOSTIC LABORATORIES 109
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 111
9.5 OTHER END USERS 114
10 REGIONAL ANALYSIS 116
10.1 INTRODUCTION 117
10.2 PEST ANALYSIS 118
10.2.1 POLITICAL FACTORS 118
10.2.2 ECONOMIC FACTORS 119
10.2.3 SOCIAL FACTORS 119
10.2.4 TECHNOLOGICAL FACTORS 119
10.3 NORTH AMERICA 120
10.3.1 U.S. 124
10.3.2 CANADA 128
10.4 EUROPE 132
10.4.1 GERMANY 136
10.4.2 FRANCE 139
10.4.3 U.K. 142
10.4.4 REST OF EUROPE (ROE) 146
10.5 ASIA-PACIFIC (APAC) 150
10.6 LATIN AMERICA (LATAM) 155
10.7 MIDDLE EAST AND AFRICA (MEA) 159

11 COMPETITIVE LANDSCAPE 164
11.1 OVERVIEW 164
11.2 MARKET SHARE ANALYSIS 165
11.3 COMPETITIVE SITUATION AND TRENDS 167
11.3.1 NEW PRODUCT LAUNCHES 167
11.3.2 PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS 169
11.3.3 EXPANSIONS 170
11.3.4 ACQUISITIONS 171
12 COMPANY PROFILE 172
12.1 INTRODUCTION 172
12.2 INTEGRATED DNA TECHNOLOGIES, INC. (IDT) 173
12.3 SIGMA-ALDRICH CORPORATION 177
12.4 EUROFINS GENOMICS 181
12.5 THERMO FISHER SCIENTIFIC, INC. 184
12.6 BIOAUTOMATION CORPORATION 190
12.7 AGILENT TECHNOLOGIES, INC. 193
12.8 BIOSEARCH TECHNOLOGIES, INC. 197
12.9 EUROGENTEC S.A. 200
12.10 GENERAL ELECTRIC COMPANY (GE) 202
12.11 GEN9, INC. 205
12.12 GENEDESIGN, INC. 207
12.13 GENSCRIPT USA INC. 208
12.14 NITTO DENKO AVECIA INC. (AVECIA) 210
12.15 TRILINK BIOTECHNOLOGIES, INC. 212
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
13 APPENDIX 215
13.1 INSIGHTS FROM INDUSTRY EXPERTS 215
13.2 DISCUSSION GUIDE 216
13.3 OTHER DEVELOPMENTS, BY COMPANY, 2012-2015 219
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 228
13.5 AVAILABLE CUSTOMIZATIONS 228
13.6 RELATED REPORTS 229


LIST OF TABLES

TABLE 1 INCREASING RandD EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IS PROPELLING THE GROWTH OF OLIGONUCLEOTIDE SYNTHESIS MARKET 48
TABLE 2 PRICE EROSION OF SYNTHESIZED OLIGOS RESTRAINTS THE GROWTH OF OLIGONUCLEOTIDE SYNTHESIS MARKET 49
TABLE 3 EMERGING ASIA-PACIFIC MARKETS ARE PAVING NEW GROWTH AVENUES FOR PLAYERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET 50
TABLE 4 LOCALIZATION OF BUSINESS CAN BE A MAJOR CHALLENGE FOR THE GROWTH OF OLIGONUCLEOTIDE SYNTHESIS MARKET 51
TABLE 5 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION,
2013-2020 (USD MILLION) 60
TABLE 6 NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 60
TABLE 7 EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY COUNTRY,
2013-2020 (USD MILLION) 60
TABLE 8 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE,
2013-2020 (USD MILLION) 62
TABLE 9 GLOBAL PRIMERS MARKET, BY REGION, 2013-2020 (USD MILLION) 63
TABLE 10 NORTH AMERICA: PRIMERS MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 63
TABLE 11 EUROPE: PRIMERS MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 63
TABLE 12 GLOBAL PROBES MARKET, BY REGION, 2013-2020 (USD MILLION) 64
TABLE 13 NORTH AMERICA: PROBES MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 65
TABLE 14 EUROPE: PROBES MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 65
TABLE 15 GLOBAL LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 16 NORTH AMERICA: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET,
BY COUNTRY, 2013-2020 (USD MILLION) 66
TABLE 17 EUROPE: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 67
TABLE 18 GLOBAL INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET,
BY REGION, 2013-2020 (USD MILLION) 68
TABLE 19 NORTH AMERICA: INTERMEDIATE SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 68
TABLE 20 EUROPE: INTERMEDIATE SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET,
BY COUNTRY, 2013-2020 (USD MILLION) 68
TABLE 21 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE,
2013-2020 (USD MILLION) 69
TABLE 22 GLOBAL CUSTOM OLIGONUCLEOTIDES MARKET, BY REGION,
2013-2020 (USD MILLION) 70
TABLE 23 NORTH AMERICA: CUSTOM OLIGONUCLEOTIDES MARKET, BY COUNTRY,
2013-2020 (USD MILLION) 71
TABLE 24 EUROPE: CUSTOM OLIGONUCLEOTIDES MARKET, BY COUNTRY,
2013-2020 (USD MILLION) 71
TABLE 25 GLOBAL PRE-DESIGNED OLIGONUCLEOTIDES MARKET, BY REGION,
2013-2020 (USD MILLION) 72
TABLE 26 NORTH AMERICA: PRE-DESIGNED OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 72
TABLE 27 EUROPE: PRE-DESIGNED OLIGONUCLEOTIDES MARKET, BY COUNTRY,
2013-2020 (USD MILLION) 73
TABLE 28 GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION,
2013-2020 (USD MILLION) 74
TABLE 29 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET,
BY COUNTRY, 2013-2020 (USD MILLION) 74
TABLE 30 EUROPE: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 75
TABLE 31 GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION,
2013-2020 (USD MILLION) 76
TABLE 32 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET,
BY COUNTRY, 2013-2020 (USD MILLION) 76
TABLE 33 EUROPE: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2013-2020 (USD MILLION) 77
TABLE 34 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 80
TABLE 35 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 81
TABLE 36 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 82
TABLE 37 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 82
TABLE 38 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 82
TABLE 39 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 83
TABLE 40 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 84
TABLE 41 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 84
TABLE 42 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 85
TABLE 43 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 85
TABLE 44 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS,
BY COUNTRY, 2013-2020 (USD MILLION) 86
TABLE 45 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 87
TABLE 46 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 87
TABLE 47 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 88
TABLE 48 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 89
TABLE 49 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 89
TABLE 50 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 90
TABLE 51 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 91
TABLE 52 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 91
TABLE 53 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 91
TABLE 54 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 93
TABLE 55 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 94
TABLE 56 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 94
TABLE 57 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 96
TABLE 58 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 97
TABLE 59 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 97
TABLE 60 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 97
TABLE 61 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGOS APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 98
TABLE 62 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGOS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 99
TABLE 63 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGOS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 99
TABLE 64 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY REGION, 2013-2020 (USD MILLION 100
TABLE 65 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 101
TABLE 66 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 101
TABLE 67 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 102
TABLE 68 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 102
TABLE 69 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION) 103
TABLE 70 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2013-2020 (USD THOUSAND) 103
TABLE 71 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD THOUSAND) 104
TABLE 72 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD THOUSAND) 104
TABLE 73 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2013-2020 (USD MILLION) 107
TABLE 74 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION) 108
TABLE 75 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION) 109
TABLE 76 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION) 109
TABLE 77 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION) 110
TABLE 78 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION) 111
TABLE 79 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION) 111
TABLE 80 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION) 112
TABLE 81 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2013-2020 (USD MILLION) 113
TABLE 82 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION) 113
TABLE 83 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION) 114
TABLE 84 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER
END USERS, BY COUNTRY, 2013-2020 (USD MILLION) 114
TABLE 85 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION) 115
TABLE 86 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 117
TABLE 87 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 117
TABLE 88 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 118
TABLE 89 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS
and SERVICES, 2013-2020 (USD MILLION) 121
TABLE 90 NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 122
TABLE 91 NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE,
BY SERVICE, 2013-2020 (USD MILLION) 122
TABLE 92 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 122
TABLE 93 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 123
TABLE 94 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 123
TABLE 95 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 124
TABLE 96 U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 125
TABLE 97 U.S.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 125
TABLE 98 U.S.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 126
TABLE 99 U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 126
TABLE 100 U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 126
TABLE 101 U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 127
TABLE 102 U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 127
TABLE 103 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 128
TABLE 104 CANADA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 129
TABLE 105 CANADA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 129
TABLE 106 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 129
TABLE 107 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 130
TABLE 108 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 130
TABLE 109 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 131
TABLE 110 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 133
TABLE 111 EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 133
TABLE 112 EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 134
TABLE 113 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 134
TABLE 114 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 134
TABLE 115 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 135
TABLE 116 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 135
TABLE 117 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 136
TABLE 118 GERMANY: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 137
TABLE 119 GERMANY: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 137
TABLE 120 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 137
TABLE 121 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 138
TABLE 122 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 138
TABLE 123 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 139
TABLE 124 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 140
TABLE 125 FRANCE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 140
TABLE 126 FRANCE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 140
TABLE 127 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 141
TABLE 128 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 141
TABLE 129 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 142
TABLE 130 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 142
TABLE 131 U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 143
TABLE 132 U.K.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 143
TABLE 133 U.K.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 144
TABLE 134 U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 144
TABLE 135 U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 144
TABLE 136 U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 145
TABLE 137 U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 145
TABLE 138 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 146
TABLE 139 ROE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 147
TABLE 140 ROE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE,
2013-2020 (USD MILLION) 147
TABLE 141 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 147
TABLE 142 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 148
TABLE 143 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 148
TABLE 144 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 149
TABLE 145 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS
and SERVICES, 2013-2020 (USD MILLION) 151
TABLE 146 ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 152
TABLE 147 ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION) 152
TABLE 148 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 153
TABLE 149 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 153
TABLE 150 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 154
TABLE 151 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 154
TABLE 152 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS
and SERVICES, 2013-2020 (USD MILLION) 156
TABLE 153 LATIN AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 156
TABLE 154 LATIN AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION) 157
TABLE 155 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 157
TABLE 156 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 157
TABLE 157 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 158
TABLE 158 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 158
TABLE 159 MIDDLE EAST and AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS and SERVICES, 2013-2020 (USD MILLION) 160
TABLE 160 MIDDLE EAST and AFRICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 161
TABLE 161 MIDDLE EAST and AFRICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE,
BY SERVICE, 2013-2020 (USD MILLION) 161
TABLE 162 MIDDLE EAST and AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 161
TABLE 163 MIDDLE EAST and AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE
FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 162
TABLE 164 MIDDLE EAST and AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE
FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION) 162
TABLE 165 MIDDLE EAST and AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE,
BY END USER, 2013-2020 (USD MILLION) 163
TABLE 166 NEW PRODUCT LAUNCHES (2012-2015) 168
TABLE 167 PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS (2012-2015) 169
TABLE 168 EXPANSIONS (2012-2015) 170
TABLE 169 ACQUISITIONS (2012-2015) 171
TABLE 170 AGILENT TECHNOLOGIES, INC. 219
TABLE 171 BIOAUTOMATION CORPORATION 220
TABLE 172 BIOSEARCH TECHNOLOGIES 220
TABLE 173 EUROFINS GENOMICS 221
TABLE 174 EUROGENTEC S.A. 221
TABLE 175 GENERAL ELECTRIC COMPANY (GE) 222
TABLE 176 GEN9, INC. 222
TABLE 177 GENDESIGN, INC. 222
TABLE 178 GENSCRIPT USA, INC. 223
TABLE 179 INTEGRATED DNA TECHNOLOGIES, INC. (IDT) 223
TABLE 180 NITTO DENKO AVECIA, INC. (AVECIA) 225
TABLE 181 SIGMA-ALDRICH CORPORATION 225
TABLE 182 THERMO FISHER SCIENTIFIC, INC. 226
TABLE 183 TRILINK BIOTECHNOLOGIES, INC. 227


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 25
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 26
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 28
FIGURE 5 DATA TRIANGULATION METHODOLOGY 29
FIGURE 6 KEY DATA FROM SECONDARY SOURCES 30
FIGURE 7 KEY DATA FROM PRIMARY SOURCES 31
FIGURE 8 SYNTHESIZED OLIGONUCLEOTIDES SEGMENT TO DOMINATE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET DURING THE FORECAST PERIOD 34
FIGURE 9 INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES SEGMENT TO GROW AT THE HIGHEST RATE (2015-2020) 34
FIGURE 10 CUSTOM OLIGOS SEGMENT TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES 35
FIGURE 11 RESEARCH SEGMENT TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS APPLICATIONS MARKET (2015) 36
FIGURE 12 DIAGNOSTIC LABORATORIES END-USER SEGMENT TO GROW AT THE HIGHEST CAGR (2015-2020) 36
FIGURE 13 NORTH AMERICA EXPECTED TO HOLD THE LARGEST SHARE IN 2015, ASIA-PACIFIC TO WITNESS HIGHEST GROWTH (2015-2020) 37
FIGURE 14 SYNTHESIZED OLIGONUCLEOTIDES SEGMENT TO OFFER HIGH GROWTH OPPORTUNITIES FOR THE OLIGONUCLEOTIDE SYNTHESIS MARKET 38
FIGURE 15 PRIMERS EXPECTED TO BE THE MAJOR CONTRIBUTING SEGMENT BETWEEN
2015 TO 2020 38
FIGURE 16 CUSTOM OLIGOS TO DOMINATE THE SYNTHESIZED OLIGONUCLEOTIDES SERVICES SEGMENT FROM 2015 TO 2020 39
FIGURE 17 PCR TO COMMAND THE LARGEST SHARE OF THE RESEARCH APPLICATIONS MARKET IN 2015 39
FIGURE 18 RNAI SEGMENT EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 40
FIGURE 19 DIAGNOSTIC LABORATORIES SEGMENT TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD 40
FIGURE 20 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 41
FIGURE 21 OLIGONUCLEOTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
FIGURE 22 PRICE EROSION AFFECTING INDUSTRY GROWTH 53
FIGURE 23 SYNTHESIZED OLIGONUCLEOTIDES TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 58
FIGURE 24 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 59
FIGURE 25 INTERMEDIATE SCALE SYNTHESIS SEGMENT TO GROW AT THE HIGHEST RATE 61
FIGURE 26 CUSTOM OLIGONUCLEOTIDES DOMINATES THE OLIGONUCLEOTIDE SYNTHESIS MARKET BY SERVICES IN 2015 69
FIGURE 27 NORTH AMERICA TO DOMINATE THE REAGENTS MARKET IN 2015 73
FIGURE 28 ASIA-PACIFIC TO GROW AT A HIGHEST CAGR DURING THE FORECAST PERIOD 75
FIGURE 29 THE DIAGNOSTIC APPLICATIONS SEGMENT OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR MARKET PLAYERS DURING THE FORECAST PERIOD 79
FIGURE 30 THE PCR SEGMENT TO DOMINATE THE RESEARCH APPLICATIONS MARKET
IN 2015 81
FIGURE 31 ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 93
FIGURE 32 THE RNAI SEGMENT TO DOMINATE THE THERAPEUTIC APPLICATIONS MARKET
IN 2015 96
FIGURE 33 DIAGNOSTIC LABORATORIES TO OFFER LUCRATIVE GROWTH OPPORTUNITIES 106
FIGURE 34 ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 108
FIGURE 35 ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 110
FIGURE 36 NORTH AMERICA TO DOMINATE THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT IN 2015 112
FIGURE 37 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 120
FIGURE 38 EUROPEAN OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 132
FIGURE 39 ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET 150
FIGURE 40 LATIN AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 155
FIGURE 41 MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 159
FIGURE 42 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2012 AND 2015 164
FIGURE 43 MARKET EVOLUTION FRAMEWORK 165
FIGURE 44 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 165
FIGURE 45 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS 167
FIGURE 46 OLIGONUCLEOTIDE SYNTHESIS BENCHMARKING FOR TOP 5 PLAYERS 172
FIGURE 47 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 177
FIGURE 48 EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT 181
FIGURE 49 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 184
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 193
FIGURE 51 KANEKA CORPORATION: COMPANY SNAPSHOT 200
FIGURE 52 GENERAL ELECTRIC COMPANY (GE): COMPANY SNAPSHOT 202
FIGURE 53 NITTO DENKO GROUP: COMPANY SNAPSHOT 210

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Idera Pharmaceutical Cancer Drugs Clinical Pipeline Insight

Idera Pharmaceutical Cancer Drugs Clinical Pipeline Insight

  • $ 500
  • Industry report
  • November 2016
  • by PNS Pharma

“Idera Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Idera Pharmaceutical. This report highlights various ...

GLOBAL PRENATAL & MATERNAL DIAGNOSTIC MARKET TO 2021

GLOBAL PRENATAL & MATERNAL DIAGNOSTIC MARKET TO 2021

  • $ 3800
  • Industry report
  • September 2016
  • by Kelly Scientific Publications

Prenatal tests (fetus, embryos and newborns) currently on the market analyze chromosomes, DNA, RNA, genes, and/or gene products to determine whether an abnormality is present that is causative of a specific ...

Global Molecular Cytogenetics Industry

Global Molecular Cytogenetics Industry

  • $ 4950
  • Industry report
  • May 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Molecular Cytogenetics in US$ Thousand by the following Technologies: Fluorescence In Situ Hybridization, Array-based Technology. The report provides separate ...

Global Biochip Industry

February 2016 $ 4950

Download Unlimited Documents from Trusted Public Sources

Genomics Industry in the US, Quarterly Update

  • November 2016
    9 pages
  • Genomics  

  • United States  

View report >

Cytogenetic Industry in Denmark and Qatar

  • November 2016
    4 pages
  • Cytogenetic  

    Shark  

  • Denmark  

View report >

Genomics Industry

  • October 2016
    17 pages
  • Genomics  

  • Oceania  

    Tonga  

    Vanuatu  

View report >

Global Dna Industry

2 months ago

Global Dna Industry

2 months ago

Global Dna Industry

2 months ago

Related Market Segments :

Oligonucleotide
Biotechnology

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.